Markets
INO

Sector Update: Healthcare

Healthcare shares were generally higher in pre-market trade on Monday.

In healthcare stocks news, Inovio Pharmaceuticals ( INO ) Monday reported net loss attributable to common stockholders of $10 million, or $0.05 per share, for Q1 ended March 31, 2014 versus last year's net loss of $6.6 million, or $0.04 per share. The increase in loss came from an increase in non-cash stock-based compensation. The Capital IQ consensus was for a $0.04 loss per share.

The biotechnology company generated $2.4 million in revenues versus $1.5 million for the same period in 2013. The average estimate by five analysts, according to the Capital IQ consensus was for revenues of $1.4 million.

And, SciClone ( SCLN ) reported Q1 loss of $0.10 per share, which beat the analyst consensus for a $0.08 per share loss. Revenue of $26.6 million missed the Street view.

Finally, Flamel Technologies ( FLML ) said its Q1 adjusted net loss narrowed as sales topped estimates, with the company recognizing revenue from Bloxiverz for the first time.

Bloxiverz is the first of a line of products acquired from Eclat to receive U.S. Food and Drug Administration approval.

The adjusted net loss was $4.2 million, or $0.15 a share versus an adjusted net loss of $5.9 million or $0.23 a share in the first quarter of 2013, in line with analysts' estimates.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

INO

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More